Toll-like receptor 3 (TLR3) variant and NLRP12 mutation confer susceptibility to a complex clinical presentation
- 1 March 2020
- journal article
- research article
- Published by Elsevier in Clinical Immunology
- Vol. 212, 30-34
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Heterozygous TBK1 mutations impair TLR3 immunity and underlie herpes simplex encephalitis of childhoodJournal of Experimental Medicine, 2012
- Herpes Esophagitis Presenting as Vocal Fold Palsy in Immunocompetent HostOtolaryngology–Head and Neck Surgery, 2011
- Herpes simplex encephalitis in children with autosomal recessive and dominant TRIF deficiencyJournal of Clinical Investigation, 2011
- Herpes simplex virus encephalitis in a patient with complete TLR3 deficiency: TLR3 is otherwise redundant in protective immunityJournal of Experimental Medicine, 2011
- The L412F variant of Toll-like receptor 3 (TLR3) is associated with cutaneous candidiasis, increased susceptibility to cytomegalovirus, and autoimmunityJournal of Allergy and Clinical Immunology, 2011
- Human TRAF3 Adaptor Molecule Deficiency Leads to Impaired Toll-like Receptor 3 Response and Susceptibility to Herpes Simplex EncephalitisImmunity, 2010
- Mutations in NALP12 cause hereditary periodic fever syndromesProceedings of the National Academy of Sciences, 2008
- Human Toll‐like receptor‐dependent induction of interferons in protective immunity to virusesImmunological Reviews, 2007
- TLR signalingSeminars in Immunology, 2007
- Herpes Simplex Virus Encephalitis in Human UNC-93B DeficiencyScience, 2006